Cibc World Market Inc. Ascendis Pharma A/S Put Options Transaction History
Cibc World Market Inc.
- $52.7 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ASND
# of Institutions
288Shares Held
60.6MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.02 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$976 Million15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$868 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$834 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...